Asian Pacific Journal of Cancer Prevention · 2013 · 98 citations · 52 references
MedicineOncologyPreventive MedicineCancer EpidemiologyCancer PreventionCancer ScreeningCancer SurveillanceColorectal CancerGastrointestinal EndoscopyPopulation ScreeningPopulation-based Cancer ControlScreeningCervical Cancer PrevalenceCervical Cancer ScreeningColorectal Cancer ScreeningEndoscopic ScreeningGastric Cancer PrevalenceGastric Cancer ScreeningLiver Cancer PrevalenceScreening Participation Rates
To investigate the participation rates in gastric, liver, colorectal, breast, and cervical cancer screening in Korea, including both organised and opportunistic programmes, a nationwide interview survey using multi-stage random sampling was conducted in 2010. A total of 4,056 cancer-free men aged over 40 years and women aged 30 years participated. Lifetime screening rates ranged from 54.2% (liver cancer) to 79.5% (breast cancer) and rates of screening in accordance with guidelines ranged from 22.9% (liver cancer) to 65.1% (gastric cancer). Upper endoscopy was the preferred method for gastric cancer, whereas the faecal occult blood test was conducted most often for colorectal cancer. The main reason stated for non attendance was 'no symptoms'. To increase attendance at cancer-screening programmes, efforts to increase education and accessibility of screening programmes are necessary.
52
Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2009
Kyu‐Won Jung, Sohee Park, Hyun-Joo Kong et al. · Cancer Research and Treatment · 2012 · 452 citations
Medicine, Oncology, Cancer Control +16
Cancer Statistics in Korea: Incidence, Mortality, Survival and Prevalence in 2010
Kyu‐Won Jung, Young‐Joo Won, Hyun-Joo Kong et al. · Cancer Research and Treatment · 2013 · 431 citations · Full text
Medicine, Oncology, Cancer Control +16
Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2008
Kyu‐Won Jung, Sohee Park, Hyun-Joo Kong et al. · Cancer Research and Treatment · 2011 · 231 citations · Full text
Medicine, Oncology, Cancer Control +16